Multifunctional gold nanoparticle based selective detection of esophageal squamous cell carcinoma cells using resonance Rayleigh scattering assay

Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers in China. Early and accurate diagnosis is the key to effective treatment of this disease. In this work, a resonance Rayleigh scattering (RRS) strategy was established to determine the concentration of epidermal growth factor receptor (EGFR) overexpressed ESCC cancer cells, which based on the selective binding of the anti-EGFR aptamer (Apt) and anti-EGFR antibody (Ab) multi-functionalized gold nanoparticles (AuNPs) probe (Apt-AuNPs-Ab) to the EGFR-positive cancer cell. When the probe was mixed with the Eca109 ESCC cancer cell, a distinct RRS intensity increase was observed. The probe possesses a dynamic range from 1.0 x 10(2)-5.0 x 10(5) cell.mL(-1) for Eca109 cells, and the detection limit is 20 cell.mL(-1). Experimental results with the A2780 ovarian cancer cells line, as well as with the Eca109 ESCC cancer cell line, clearly demonstrated that the RRS assay was sensitive and selective to Eca109 than the other cancer cell lines that express a low level of EGFR. The proposed RRS assay provided a novel platform for detection of EGFR-positive cancer cells and shown the good potential for clinical diagnostics.

Automated summary

The study established a novel method based on RRS strategy for accurate diagnosis of ESCC cancer cells with EGFR overexpression, showing good selectivity and sensitivity. The method has the potential for clinical application in diagnostics.